Vps34-mediated macropinocytosis in Tuberous Sclerosis Complex 2-deficient cells supports tumorigenesis

Scientific Reports
Harilaos FilippakisElizabeth P Henske

Abstract

Tuberous Sclerosis Complex (TSC), a rare genetic disorder with mechanistic target of rapamycin complex 1 (mTORC1) hyperactivation, is characterized by multi-organ hamartomatous benign tumors including brain, skin, kidney, and lung (Lymphangioleiomyomatosis). mTORC1 hyperactivation drives metabolic reprogramming including glucose and glutamine utilization, protein, nucleic acid and lipid synthesis. To investigate the mechanisms of exogenous nutrients uptake in Tsc2-deficient cells, we measured dextran uptake, a polysaccharide internalized via macropinocytosis. Tsc2-deficient cells showed a striking increase in dextran uptake (3-fold, p < 0.0001) relative to Tsc2-expressing cells, which was decreased (3-fold, p < 0.0001) with mTOR inhibitor, Torin1. Pharmacologic and genetic inhibition of the lipid kinase Vps34 markedly abrogated uptake of Dextran in Tsc2-deficient cells. Macropinocytosis was further increased in Tsc2-deficient cells that lack autophagic mechanisms, suggesting that autophagy inhibition leads to dependence on exogenous nutrient uptake in Tsc2-deficient cells. Treatment with a macropinocytosis inhibitor, ethylisopropylamiloride (EIPA), resulted in selective growth inhibition of Atg5-deficient, Tsc2-deficient cells ...Continue Reading

References

Aug 8, 1997·Science·M van SlegtenhorstD J Kwiatkowski
Sep 29, 2006·The New England Journal of Medicine·Peter B CrinoElizabeth Petri Henske
Jan 11, 2008·The New England Journal of Medicine·John J BisslerDavid N Franz
Jul 10, 2008·Nature Reviews. Molecular Cell Biology·Joel A Swanson
Feb 5, 2009·Traffic·Markus C Kerr, Rohan D Teasdale
Apr 3, 2009·Nature Reviews. Molecular Cell Biology·Xiaoju Max Ma, John Blenis
Aug 6, 2009·Annual Review of Genetics·Congcong He, Daniel J Klionsky
Jan 9, 2010·Current Opinion in Cell Biology·Noboru Mizushima
Feb 17, 2010·The Journal of Cell Biology·Mirkka KoivusaloSergio Grinstein
Mar 18, 2011·The New England Journal of Medicine·Francis X McCormackUNKNOWN MILES Trial Group
Jul 13, 2011·Proceedings of the National Academy of Sciences of the United States of America·Andrey ParkhitkoElizabeth Petri Henske
Dec 4, 2013·Molecular Cancer Research : MCR·Andrey A ParkhitkoElizabeth P Henske
Jan 5, 2014·Nature Protocols·Cosimo CommissoDafna Bar-Sagi
Feb 22, 2014·Nature Reviews. Molecular Cell Biology·Mitsugu Shimobayashi, Michael N Hall
Oct 20, 2014·Nature Chemical Biology·Baptiste RonanBenoit Pasquier
Mar 18, 2015·American Journal of Respiratory Cell and Molecular Biology·Carmen PrioloElizabeth P Henske
May 27, 2016·Nature Reviews. Disease Primers·Elizabeth P HenskeElizabeth A Thiele
Jul 7, 2016·Nature Reviews. Molecular Cell Biology·Jean-Claude Farré, Suresh Subramani
Sep 14, 2016·Developmental Cell·Shefali KrishnaMichael Overholtzer
Nov 2, 2016·The Journal of Clinical Investigation·Seong M KimAimee L Edinger
Dec 27, 2016·Nature Medicine·Shawn M DavidsonMatthew G Vander Heiden
Apr 8, 2017·Cell·Robert A Saxton, David M Sabatini
Aug 2, 2017·Molecular Cell·Goran StjepanovicJames H Hurley
Mar 7, 2018·Human Molecular Genetics·Barbara OgórekElizabeth P Henske

❮ Previous
Next ❯

Citations

Apr 7, 2021·Genetics and Molecular Biology·Larissa Brussa ReisClévia Rosset

❮ Previous
Next ❯

Methods Mentioned

BETA
fluorescence microscopy
flow cytometry
PCR
Confocal microscopy
xenograft
Transgenic

Software Mentioned

Treestar
GraphPad Prism
GraphPad
FlowJo

Related Concepts

Related Feeds

Autophagosome

An autophagosome is the formation of double-membrane vesicles that involve numerous proteins and cytoplasmic components. These double-membrane vesicles are then terminated at the lysosome where they are degraded. Discover the latest research on autophagosomes here.

Autophagy & Model Organisms

Autophagy is a cellular process that allows degradation by the lysosome of cytoplasmic components such as proteins or organelles. Here is the latest research on autophagy & model organisms

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.

Autophagosome

An autophagosome is the formation of double-membrane vesicles that involve numerous proteins and cytoplasmic components. These double-membrane vesicles are then terminated at the lysosome where they are degraded. Discover the latest research on autophagosomes here.